Meet the New Addgene Board Members!
Type
Blog Post
...was the Head of Oncology Target Discovery at the Novartis Institutes for Biomedical Research.
Drug development... genetics.”
As a postdoc in Stephen Elledge at Harvard Medical School, he developed the first lentiviral...are less common, they can be very impactful. At Novartis, Stegmeier deposited the ClonTracer Barcoding ...an Associate Professor at Mass Eye and Ear and Harvard Medical School (HMS) where he leads a lab of 25...also teaches at HMS and has been involved in a variety of commercialization efforts in gene therapy either... an Associate Member at the Broad Institute of Harvard and MIT.
...